Myeloma of the central nervous system: association with high‐risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations
- 25 March 2002
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 117 (1) , 103-108
- https://doi.org/10.1046/j.1365-2141.2002.03401.x
Abstract
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.Keywords
This publication has 17 references indexed in Scilit:
- High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusionsBlood, 2001
- Cerebral and meningeal multiple myeloma after autologous stem cell transplantation. A case report and review of the literatureAmerican Journal of Hematology, 1999
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaNew England Journal of Medicine, 1999
- Central nervous system relapses after autologous stem cell transplantation for myeloma. Report of two cases.Hematology and Cell Therapy, 1997
- Superiority of Tandem Autologous Transplantation Over Standard Therapy for Previously Untreated Multiple MyelomaBlood, 1997
- Graft-versus-myeloma effect: proof of principleBlood, 1996
- Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalitiesBlood, 1995
- Leptomeningeal myelomatosis presenting with mental status changes and other neurologic findingsCancer, 1992
- High Serum Lactate Dehydrogenase Level as a Marker for Drug Resistance and Short Survival in Multiple MyelomaAnnals of Internal Medicine, 1991
- Incidence, Prognostic Significance and Therapeutic Modalities of Central Nervous System Involvement in Multiple MyelomaActa Haematologica, 1982